🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
A multicenter randomized controlled trial on prevention and treatment of oc...
Status
Unknown
Location
Yingli Li
Start Date
2018-06
Trial ID
NCT03515187
Phase 3 study to evaluate the extended safety of RVL-1201 compared to place...
Status
Completed
Location
Barnet, Dulany Perkins
Start Date
2018-06-20
Trial ID
NCT03536949
Treatments Being Tested
The purpose of this Phase 1b study is to evaluate the safety, tolerability,...
Status
Completed
Location
PPD
Start Date
2019-05-02
Trial ID
NCT04284514
Treatments Being Tested
The purpose of this study was to describe the safety and IOP-lowering effic...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00670033
The purpose of this study is to evaluate the safety and intraocular pressur...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00761709
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of CsA opht...
Status
Completed
Location
Ophthalmological Center of Zhongshan University
Start Date
2020-11-05
Trial ID
NCT04541888
Treatments Being Tested
This is a phase I study evaluating safety and tolerability through the inci...
Status
Completed
Location
Investigacion e Innovacion en Medicina Traslacional
Start Date
2024-02-08
Trial ID
NCT06352541
A randomized, controlled, double-masked, investigator-initiated trial to ev...
Status
Completed
Location
Stephenson Eye Associates
Start Date
2022-10-11
Trial ID
NCT05514041
Treatments Being Tested